Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular mimicry and autoimmunity in the time of COVID-19
Manuel Rojas, María Herrán, Carolina Ramírez‐Santana, et al.
Journal of Autoimmunity (2023) Vol. 139, pp. 103070-103070
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Increased incidence of rheumatoid arthritis after COVID-19
Juan Sebastián Marín, Enrique A. Mazenett-Granados, Juan Carlos Salazar, et al.
Autoimmunity Reviews (2023) Vol. 22, Iss. 10, pp. 103409-103409
Open Access | Times Cited: 23
COVID-19 mRNA Vaccines: Lessons Learned from the Registrational Trials and Global Vaccination Campaign
M. Nathaniel Mead, Stephanie Seneff, Russ Wolfinger, et al.
Cureus (2024)
Open Access | Times Cited: 13
COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 1
M. Nathaniel Mead, Stephanie Seneff, Russ Wolfinger, et al.
International Journal of Vaccine Theory Practice and Research (2024) Vol. 3, Iss. 2, pp. 1112-1178
Closed Access | Times Cited: 6
Coronavirus disease 2019 (COVID-19) pandemic and autoimmune rheumatic diseases: Outcomes and prospects
Е. Л. Насонов
Rheumatology Science and Practice (2024) Vol. 62, Iss. 1, pp. 32-54
Open Access | Times Cited: 5
Autoimmune hepatitis under the COVID-19 veil: an analysis of the nature of potential associations
Chaojie Yu, Wenrui Wang, Qian Zhang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Prevalence of anti-nuclear antibodies in COVID-19 patients: a remarkable 2.5-fold rise compared to healthy controls
Faruk Dişli, Sedat Yıldız
Irish Journal of Medical Science (1971 -) (2025)
Open Access
NETosis: A Key Player in Autoimmunity, COVID-19, and Long COVID
Diana M. Monsalve, Yeny Acosta‐Ampudia, Nicolás Guerrero Acosta, et al.
Journal of Translational Autoimmunity (2025) Vol. 10, pp. 100280-100280
Open Access
The impact of COVID-19 on autoimmune diseases
Altijana Hromić-Jahjefendić, Abas Sezer, Irma Mahmuljin
Progress in molecular biology and translational science (2025)
Closed Access
Molecular Mimicry Impact of the COVID-19 Pandemic: Sequence Homology Between SARS-CoV-2 and Autoimmune Diseases Epitopes
Pablo Maldonado-Catala, Ramkiran Gouripeddi, Naomi Schlesinger, et al.
ImmunoInformatics (2025), pp. 100050-100050
Open Access
Neutralizing and Enhancing Monoclonal Antibodies in SARS-CoV-2 Convalescent Patients: Lessons from Early Variant Infection and Impact on Shaping Emerging Variants
Frédéric Coutant, Franck Touret, Jean‐Jacques Pin, et al.
Emerging Microbes & Infections (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Unraveling the enigma of long COVID: novel aspects in pathogenesis, diagnosis, and treatment protocols
Abdul Mannan Baig, Sandy Rosko, B.R. Jaeger, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 4, pp. 2075-2090
Closed Access | Times Cited: 4
Central nervous system immune-related disorders after SARS-CoV-2 vaccination: a multicenter study
Alberto Vogrig, Sara Tartaglia, Marta Dentoni, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
The Ambivalence of Post COVID-19 Vaccination Responses in Humans
Radha Gopalaswamy, Vivekanandhan Aravindhan, Selvakumar Subbian
Biomolecules (2024) Vol. 14, Iss. 10, pp. 1320-1320
Open Access | Times Cited: 3
Rheumatoid Arthritis and COVID-19 at the Intersection of Immunology and Infectious Diseases: A Related PRISMA Systematic Literature Review
Andreea-Iulia Vlădulescu-Trandafir, Violeta‐Claudia Bojincă, Constantin Munteanu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11149-11149
Open Access | Times Cited: 3
COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 2
M. Nathaniel Mead, Stephanie Seneff, Jessica Rose, et al.
International Journal of Vaccine Theory Practice and Research (2024) Vol. 3, Iss. 2, pp. 1275-1344
Open Access | Times Cited: 2
Tackling persistent neurological symptoms in patients following acute COVID-19 infection: an update of the literature
Eder Cáceres, Afshin A. Divani, André Emilio Viñán Garcés, et al.
Expert Review of Neurotherapeutics (2024), pp. 1-17
Open Access | Times Cited: 2
Update on coronavirus disease 2019: Ophthalmic Manifestations and Adverse Reactions to Vaccination
Timothy P.H. Lin, Mrittika Sen, Vishali Gupta, et al.
Asia-Pacific Journal of Ophthalmology (2023) Vol. 12, Iss. 6, pp. 512-536
Open Access | Times Cited: 5
New-Onset Diabetes Mellitus after COVID-19: Combined Effects of SARS-CoV-2 Variants, Molecular Mimicry, and m6A RNA Methylation
Jorge Luis Batista-Roche, Marian Mirabent-Casals, Dahís Manzanares, et al.
COVID (2024) Vol. 4, Iss. 4, pp. 481-494
Open Access | Times Cited: 1
Comprehensive insights into COVID-19 vaccine-associated multiple evanescent white dot syndrome (MEWDS): A systematic analysis of reported cases
Yuqin Zeng, DU Zhenzhen, Chuhan Shao, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Antigen-specific T cells and autoimmunity
Manuel Rojas, Yeny Acosta‐Ampudia, Luke S. Heuer, et al.
Journal of Autoimmunity (2024) Vol. 148, pp. 103303-103303
Closed Access | Times Cited: 1
In silico design of a novel hybrid epitope-based antigen harboring highly exposed immunogenic peptides of BamA, OmpA, and Omp34 against Acinetobacter baumannii
Anahita Hessami, Zahra Mogharari, Fatemeh Rahim, et al.
International Immunopharmacology (2024) Vol. 142, pp. 113066-113066
Closed Access | Times Cited: 1
Immune Jumping in Autoimmune Long-Covid
Heinz Kohler
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy (2024)
Closed Access | Times Cited: 1
Antiphospholipid antibodies are enriched post-acute COVID-19 but do not modulate the thrombotic risk
Marc Emmenegger, Vishalini Emmenegger, Srikanth Mairpady Shambat, et al.
Clinical Immunology (2023) Vol. 257, pp. 109845-109845
Open Access | Times Cited: 3
Possible temporal relationship between SARS-CoV-2 infection and anti-NMDA receptor encephalitis: a meta-analysis
Veronika Vasilevska, Paul C. Guest, Michael Szardenings, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access
Case report: A case of anti-glycine receptor encephalomyelitis triggered by post-transplant or COVID-19 infection?
Zhengxue Zhang, Xiang Zhang, Mingming Dai, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access
Page 1 - Next Page

Scroll to top